1. MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
   Meysam Moghbeli, 2021, J Ovarian Res CrossRef
2. MicroRNA as a Potential Therapeutic Molecule in Cancer
   Joanna Szczepanek et al, 2022, Cells CrossRef
3. Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206
   Xinxin Xue et al, 2022, Bioengineered CrossRef
4. Long Non-coding RNAs (lncRNAs) signaling in Cancer Chemoresistance: From Prediction to Druggability
   Giasemi C. Eptaminitaki et al, 2022, Drug Resistance Updates CrossRef
5. Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.
   Ziyue Huang et al, 2023, Clin Chim Acta CrossRef
6. A review on the role of HAND2-AS1 in cancer
   Soudeh Ghafouri-Fard et al, 2023, Clin Exp Med CrossRef
7. Distinct HAND2/HAND2-AS1 Expression Levels May Fine-Tune Mesenchymal and Epithelial Cell Plasticity of Human Mesenchymal Stem Cells
   Rachel Vazana-Netzarim et al, 2023, IJMS CrossRef
8. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance
   Di Wu et al, 2024, Biochemical Pharmacology CrossRef
9. Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancer
   Eleonora A. Braga et al, 2024, IJMS CrossRef
10. HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis
    Zheng Song et al, 2025, CCDT CrossRef